ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print March 5, 2008
Eur Respir J 2008, doi:10.1183/09031936.00137107
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
32/1/113    most recent
09031936.00137107v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefebvre, B.
Right arrow Articles by Stanke-Labesque, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefebvre, B.
Right arrow Articles by Stanke-Labesque, F.


ORIGINAL ARTICLE

Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?

B. Lefebvre 1, J-L. Pépin 2, J-P. Baguet 3, R. Tamisier 2, M. Roustit 4, K. Riedweg 4, G. Bessard 1, P. Lévy 2, F. Stanke-Labesque 1*

1 INSERM, ERI17, Grenoble, F-38042 France; Université Grenoble 1, Faculté de Médecine, IFR1, Grenoble, F-38042 France; and CHU, Hôpital A. Michallon, Laboratoire de pharmacologie, BP217, Grenoble, F-38043 France
2 INSERM, ERI17, Grenoble, F-38042 France; Université Grenoble 1, Faculté de Médecine, IFR1, Grenoble, F-38042 France; and CHU, Hôpital A. Michallon, Laboratoire EFCR, BP217, Grenoble, F-38043 France
3 Université Grenoble 1, Faculté de Médecine, IFR1, Grenoble, F-38042 France; CHU, Hôpital A. Michallon, Clinique de cardiologie, BP217, Grenoble, F-38043 France; and INSERM, U8777, Grenoble, F-38042 France
4 CHU, Hôpital A. Michallon, Laboratoire de pharmacologie, BP217, Grenoble, F-38043 France

* To whom correspondence should be addressed. E-mail: FStanke{at}chu-grenoble.fr.


   Abstract

Severity of oxygen desaturation is predictive of early atherosclerosis in obstructive sleep apnoea (OSA). Leukotrienes B4 (LTB4) are lipid mediators involved in atherogenesis.

In 40 non obese OSA patients free of cardiovascular history and in 20 healthy volunteers, we evaluated 1/ the LTB4 production by polymorphonuclear leukocytes (PMNs) stimulated by A23187, 2/ the relationships between LTB4 production and both OSA severity and infra-clinical atherosclerosis markers. Continuous positive airway pressure (CPAP) effect on LTB4 production was also studied.

Overnight sleep study was followed by a first-morning blood sample. Isolated PMNs were stimulated by A23187 in order to induce LTB4 production that was measured by liquid chromatography-tandem mass spectrometry. Carotid intima-media thickness (IMT) and luminal diameter (LD) were measured in subset groups of 28 OSA and 11 controls.

LTB4 production was increased (p<0.05) in OSA compared to controls. LTB4 values were correlated with the mean SaO2 (r=-0.53, p<0.001) and minimal SaO2 (r=-0.51, p<0.001). LTB4 production was correlated to LD data in patients with mean SaO2≤94% but not to IMT. Lastly, CPAP significantly reduced LTB4 production by 50%.

LTB4 production is increased in OSA in relation to oxygen desaturation. LTB4 could promote early vascular remodelling in moderate to severe hypoxic OSA patients.

Keywords:  Atherosclerosis; leukotriene B4; polymorphonuclear cells; sleep apnoea







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.